Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Abstract Background Epidermal growth factor receptor (EGFR)-sensitizing mutation, exon 19 deletion consists of several molecular variants. Influences of these variants on clinical response to EGFR tyrosine kinase inhibitors remain elusive. Methods West Japan Oncology Group 8114LTR is a prospective,...

Full description

Bibliographic Details
Main Authors: Nahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, Daichi Fujimoto, Isamu Okamoto, Kazuhiko Nakagawa, Toyoaki Hida, Fumio Imamura, Satoshi Morita, Nobuyuki Yamamoto
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Cancer
Subjects:
NSCLC
Afatinib
EGFR mutation
Exon 19 deletion
Molecular subtypes
Online Access:https://doi.org/10.1186/s12885-020-6593-1

Internet

https://doi.org/10.1186/s12885-020-6593-1

Similar Items